Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Main Index

View All
Allis clamp scalp stimulation
Allodynia 48.A.4 48.A.5
Allograft rejection heart kidney
Allograft vasculopathy, cardiac 13.E.10 13.E.12
ALL
Alpha2-Adrenergic agonist
Alpha-Interferon adverse effects of for recurrent respiratory papillomatosis
Hemothorax 33.C.3 57.A.10 57.A.7 57.A.8 57.A.9 massive, definition signs and symptoms of thoracotomy for
Hemoximeter
Heparin and anesthesia in AAA repair and epidural analgesia for bariatric surgery for cardiopulmonary bypass for cardiopulmonary bypass\|in tetralogy of Fallot repair for cardiopulmonary bypass\|reversal after for ECMO patients for perioperative myocardial infarction half-life and elimination of influence, rotational thromboelastometry in influence, rotational thromboelastometry in-Figure monitoring dosage of
Heparinase
Heparin-induced thrombocytopenia, in cerebral aneurysm clipping
See Liver disease 16.A.7 16.C.3 55.B.2 6.C.5 See Liver disease
Hepatic encephalopathy 16.A.10 16.A.7 16.A.8 16.A.9 16.B.5
Alpha-Methyl-para-tyrosine, for pheochromocytoma
Alpha-Receptor blockers
Alpha-Stat method 39.C.8 5.C.II-24
Alternative Treatments
Alveolar hypoventilation, in morbidly obese patients 61.A.2 63.A.11 63.A.12
Ambulatory surgery
American College of Cardiology (ACC)/American Heart Association (AHA) guidelines on cardiovascular risk on carotid artery disease on dual antiplatelet therapy on hypertension on statin therapy
American College of Obstetricians and Gynecologists on antibiotic prophylaxis in cardiac patients on breech presentation on hypertensive disorders in pregnancy on nonobstetric surgery in pregnant patient
American College of Surgeons National Surgical Quality Improvement Program (NSQIP)
See Liver failure, acute 16.A.4 16.B.3 16.B.5 See Liver failure, acute
Hepatic metabolism, of medication
Hepatic steatosis, morbid obesity and
Hepatitis B kidney transplantation and transfusions and risk of
Hepatitis C kidney transplantation and transfusions and risk of
Hepatobiliary disease, in morbidly obese patients
Hepatopulmonary syndrome (HPS) 16.A.11 16.A.4

NDX